EllTec Analysis
← Stocks
StocksCRBNMaterialsNetherlandsPremium

Corbion

Corbion, the Dutch market leader in lactic acid and biobased ingredients, reported its strongest quarter in the recent run with rising sales and margins.

Published May 5, 2026 · Updated Nov 20, 2026 · by EllTec Analysis · Wave count: Lukas Köppl · ~23 min read · How to read this analysis →

Disclosure: the EllTec Analysis Tracking Portfolio currently holds no position in CRBN. (as of Nov 20, 2026)

For information and education only. Not investment advice. See the full disclaimer for details. Grafic source: TradingView.

In 60 seconds

Fundamentals
Corbion's third quarter 2026 was the strongest in the recent run: sales +7.6% organic and adjusted EBITDA +29.0% with an 18.8% margin, while the full-year outlook was left unchanged.
Strength
Market leadership in lactic acid and derivatives
Risk
Cyclical revenue patterns in the European chemical sector
Premium
The Elliott Wave part of this analysis is for subscribers: Risk Factors · Overall Assessment

Key figures

Interactive chartCorbionEURONEXT:CRBN

Switch the time frame (minutes to months), zoom, scroll and draw your own lines. The chart is provided by TradingView. Loading it transfers data such as your IP address to TradingView. Your choice is remembered in this browser. Privacy policy

More analyses in Stocks

All stock analyses →

New analyses by email

EllTec Analysis Updates: a short email whenever a new analysis is published or a scenario changes. Free, unsubscribe any time.

Newsletter →